NEURODERM LTD's ticker is and the CUSIP is M74231107. A total of 58 filers reported holding NEURODERM LTD in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $2,093,000 | -24.1% | 70,000 | -32.6% | 0.83% | +2.0% |
| Q1 2017 | $2,757,000 | +54.9% | 103,850 | +29.5% | 0.82% | +24.8% |
| Q4 2016 | $1,780,000 | +139.6% | 80,183 | +99.5% | 0.65% | +188.9% |
| Q3 2016 | $743,000 | +85.3% | 40,183 | +62.8% | 0.23% | +32.9% |
| Q2 2016 | $401,000 | -60.1% | 24,683 | -53.4% | 0.17% | -67.0% |
| Q2 2015 | $1,006,000 | – | 53,000 | – | 0.52% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 261,945 | $4,466,000 | 3.96% |
| ACUTA CAPITAL PARTNERS, LLC | 477,300 | $8,138,000 | 3.89% |
| Avoro Capital Advisors LLC | 520,022 | $8,866,000 | 3.05% |
| Redmile Group, LLC | 1,589,261 | $27,097,000 | 2.03% |
| NEXTHERA CAPITAL LP | 48,000 | $818,000 | 1.16% |
| SCOPIA CAPITAL MANAGEMENT LP | 2,749,038 | $46,871,000 | 0.93% |
| SENZAR ASSET MANAGEMENT, LLC | 201,700 | $3,438,985,000 | 0.38% |
| Perceptive Advisors | 270,000 | $4,604,000 | 0.34% |
| Foresite Capital Management II, LLC | 55,779 | $951,000 | 0.32% |
| RA Capital Management | 144,671 | $2,467,000 | 0.24% |